Understanding the New Treatment Era of Alternative Therapies for Patients With Hemophilia A

Downloadable slides with expert analysis on the use of EHL Factor VIII therapy for patients with hemophilia A.
Guy A. Young, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.11 MB
Released: October 29, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Related Content

Commentary from Michael Callaghan, MD, on individualizing hemophilia prophylaxis with extended half-life products and PK profiling tools, from CCO

Michael Callaghan, MD Released: November 20, 2020

Janet L. Kwiatkowski, MD, MSCE, on current and emerging therapies for beta-thalassemia in a commentary from Clinical Care Options (CCO)

Janet L. Kwiatkowski, MD, MSCE Released: November 12, 2020

Gain key clinical insights fast, with this short slideset from CCO on the management of patients with hemophilia A with Factor VIII therapy

Michael Callaghan, MD Miguel A. Escobar, MD Guy A. Young, MD Released: November 5, 2020

Downloadable slides with expert analysis on managing CVD and other comorbidities in older patients with hemophilia A, from Clinical Care Options.

Miguel A. Escobar, MD Released: October 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue